Sign in to comment!

Menu
Home

Crime & Courts

NJ-based executives with Celgene, Sanofi-Aventis charged in insider trading scheme

Two pharmaceutical company executives are among six people charged in what federal authorities in New Jersey are calling a five-year insider trading scheme.

John Lazorchak was director of financial reporting at Celgene Corp. and Mark Cupo held a similar position at Sanofi-Aventis.

The U.S. attorney's office in New Jersey says that between 2007 and 2012, Lazorchak and Cupo passed privileged information on their companies' merger and acquisition plans, financial results and regulatory applications to others who would make stock trades.

The scheme allegedly reaped $1.4 million.

Lazorchak, Cupo and the others are charged with conspiracy and multiple counts of securities fraud. Each securities fraud count carries a 20-year maximum prison sentence.

They were scheduled to appear in federal court in Newark on Monday afternoon. Their attorneys were in court and unavailable for comment.

Bank Rates

Loan Type Graph Rate +/- Last Week
30 Y Fixed Graph 3.96% dw 4.12%  
15 Y Fixed Graph 3.13% dw 3.14%  
30 Y Fixed Jumbo Graph 4.29% up 4.24%  
5/1 ARM Graph 3.11% dw 3.25%  
5/1 Jumbo ARM Graph 3.60% dw 3.61%  
Loan Type Graph Rate +/- Last Week
$30K HELOC Graph 4.65% dw 4.67%  
$50K HELOC Graph 4.02% dw 4.04%  
$30K Loan Graph 4.97% dw 5.00%  
$50K Loan Graph 4.33% dw 4.36%  
$75K Loan Graph 4.33% dw 4.36%  
Loan Type Graph Rate +/- Last Week
36 M New Graph 2.69% dw 2.70%  
36 M Used Graph 3.18% dw 3.19%  
48 M New Graph 3.02% dw 3.03%  
48 M Used Graph 2.91% -- 2.91%  
60 M New Graph 3.07% -- 3.07%  
Loan Type Graph Yield +/- Last Week
6 month Graph 0.38% dw 0.39%  
1 yr Graph 0.70% -- 0.70%  
5 yr Graph 1.50% -- 1.50%